Drug Trial Radar · NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
981
Planned (sponsor's estimate)
Start
Jun 20, 2025
Primary completion
Dec 13, 2028
Study completion Feb 14, 2029
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- May 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
DepemokimabBiological
Depemokimab as a sterile liquid formulation will be administered.
PlaceboDrug
Placebo as a sterile 0.9 percent (%) sodium chloride solution will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Moderate/Severe ExacerbationsTime frame: From Baseline up to Week 104
Locations
281 sites in 23 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Bakersfield, California · Recruiting
GSK Investigational Site
Modesto, California · Recruiting
GSK Investigational Site
Newport Beach, California · Recruiting
GSK Investigational Site
Wilmington, Delaware · Recruiting
GSK Investigational Site
Bradenton, Florida · Recruiting
GSK Investigational Site
Brandon, Florida · Recruiting
GSK Investigational Site
Hialeah, Florida · Recruiting
GSK Investigational Site
Hialeah, Florida · Recruiting
GSK Investigational Site
Loxahatchee Groves, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami Lakes, Florida · Recruiting
GSK Investigational Site
Orange City, Florida · Recruiting
GSK Investigational Site
Palm Springs, Florida · Recruiting
GSK Investigational Site
Palmetto Bay, Florida · Recruiting
GSK Investigational Site
Pensacola, Florida · Recruiting
GSK Investigational Site
Tamarac, Florida · Recruiting
GSK Investigational Site
Tampa, Florida · Recruiting
GSK Investigational Site
The Villages, Florida · Recruiting
GSK Investigational Site
Riverdale, Georgia · Recruiting
GSK Investigational Site
Stonecrest, Georgia · Recruiting
GSK Investigational Site
Chicago, Illinois · Recruiting
GSK Investigational Site
Baltimore, Maryland · Recruiting
GSK Investigational Site
Clarkston, Michigan · Recruiting
GSK Investigational Site
Flint, Michigan · Recruiting
GSK Investigational Site
St Louis, Missouri · Recruiting
GSK Investigational Site
Henderson, Nevada · Recruiting
GSK Investigational Site
Las Vegas, Nevada · Recruiting
GSK Investigational Site
Reno, Nevada · Recruiting
GSK Investigational Site
North Massapequa, New York · Recruiting
GSK Investigational Site
Winston-Salem, North Carolina · Recruiting
GSK Investigational Site
Winston-Salem, North Carolina · Recruiting
GSK Investigational Site
Greenville, South Carolina · Recruiting
GSK Investigational Site
Rock Hill, South Carolina · Recruiting
GSK Investigational Site
Franklin, Tennessee · Recruiting
GSK Investigational Site
Corsicana, Texas · Recruiting
GSK Investigational Site
Dallas, Texas · Recruiting
GSK Investigational Site
Houston, Texas · Recruiting
GSK Investigational Site
Houston, Texas · Recruiting
GSK Investigational Site
Houston, Texas · Recruiting
Showing 40 of 281 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.